Benzodiazepine reagent kits part number: 1775561PSC CD: 6550
Ended Awarded
- Contract number
- N6854625FA081
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $70,282
Award facts
- Contract value 100% obligated
- $70,282.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Fremont, CA 94538, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $70,282.08 to Microgenics Corporation for benzodiazepine reagent kits (Part Number 1775561PSC). This firm fixed-price contract, awarded on August 21, 2025, with an ultimate completion date of November 19, 2025, represents a task order against Microgenics' larger indefinite delivery contract for benzodiazepine diagnostic reagents valued at $5.5 million. The work will be performed at Microgenics' facility in Fremont, California. This award does not utilize a set-aside designation, reflecting Microgenics' established competitive position in the federal diagnostics marketplace. As a clinical diagnostics specialist and subsidiary of Thermo Electron Corporation, Microgenics manufactures high-precision immunoassay reagent test kits designed to detect controlled substances in medical screening applications.
This procurement supports the Department of Defense Drug Demand Reduction Program through the provision of critical diagnostic reagents used across military and veterans healthcare systems for substance abuse testing and treatment. Microgenics has demonstrated sustained performance as a federal contractor, supplying specialized testing solutions to multiple defense and veterans affairs agencies including the Defense Health Agency, Air Education and Training Command, and Veterans Integrated Service Networks. The company maintains a strategic role in federal toxicology screening operations, with an established portfolio of reagent kits for detecting opiates, benzodiazepines, amphetamines, and other controlled substances essential to military medical readiness and veteran healthcare objectives.
Quick answers
Who was awarded contract N6854625FA081?
N6854625FA081 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on August 21, 2025.
How much is contract N6854625FA081 worth?
The government has obligated $70,282 on N6854625FA081.
Is contract N6854625FA081 an order under another contract?
Yes. N6854625FA081 is a delivery order under N6264523D5009, an indefinite delivery contract.
Was contract N6854625FA081 competed?
The extent of competition for N6854625FA081 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award